Erenumab 140mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £24,281,090 of indicative cost of Erenumab 140mg/1ml solution for injection pre-filled disposable devices in the 12 months to June 2026, about 0.1% of all hospital medicines spend. That is up 9.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Erenumab 140mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to June 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Erenumab 140mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to June 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Sheffield Teaching Hospitals Nhs Trust | £2,408,282 |
| St George's Univ Hosps Foundation Nhst | £1,196,604 |
| The Walton Centre Nhs Foundation Trust | £1,193,512 |
| Royal Devon & Exeter Nhs Foundation Trst | £1,082,973 |
| University Hpls North Midlands Nhs Trust | £1,065,967 |
| Western Sussex Hospitals Nhs Found Trust | £1,020,747 |
| University College London Foundation Tr | £898,226 |
| Imperial College Healthcare Nhs Trust | £856,871 |
| University Hospitals Plymouth Nhs Trust | £783,436 |
| Southend Univ Hosp Nhs Foundation Trust | £778,025 |
The primary-care picture
Erenumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Erenumab medicine page.